Shares of Chinese Covid-19 vaccine developer Clover Biopharmaceuticals Ltd. fell more than 10% on its Hong Kong debut Friday before rebounding after the initial public offering (IPO) raised $240 …
( read original story …)
The HongKong News
Shares of Chinese Covid-19 vaccine developer Clover Biopharmaceuticals Ltd. fell more than 10% on its Hong Kong debut Friday before rebounding after the initial public offering (IPO) raised $240 …
( read original story …)